Universe Pharmaceuticals (UPC) Other Working Capital Changes (2021 - 2024)

Universe Pharmaceuticals has disclosed Other Working Capital Changes across 4 years of filings, most recently posting $539240.0 for Q1 2024.

• Other Working Capital Changes for Q1 2024 came in at $539240.0, down 73.18% year-over-year; the trailing twelve-month figure through Mar 2024 was $539240.0 (down 73.18% YoY), and the FY2025 annual result was -$790.0 million, down 199.66% from the prior year.
• Other Working Capital Changes came in at $539240.0 for Q1 2024 at Universe Pharmaceuticals, down from $590377.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $2.0 million in Q1 2023 to a low of $174053.0 in Q3 2021.
• The 4-year median for Other Working Capital Changes is $539240.0 (2024), against an average of $746425.0.
• Across the five-year window, Other Working Capital Changes jumped 380.73% in 2023 and plunged 73.18% in 2024, its largest moves.
• Universe Pharmaceuticals' Other Working Capital Changes stood at $174053.0 in 2021, then jumped by 140.25% to $418170.0 in 2022, then jumped by 41.18% to $590377.0 in 2023, then declined by 8.66% to $539240.0 in 2024.
• The last three Other Working Capital Changes figures came in at $539240.0 (Q1 2024), $590377.0 (Q3 2023), and $2.0 million (Q1 2023), per Business Quant data.